Wildcat Capital Management, LLC Quant / Systematic

Location: New York, NY

CIK: 0001582384 · Show all filings

Period: Q2 2025 (← Previous) (Next →)

Filing Date: Jul 18, 2025

Total Value: $168M (100.0% shares, 0.0% debt)

Holdings (6)

ULCC FRONTIER GROUP HLDGS INC 60.5%

Value $102M Shares 28,061,351 Share Price $3.63 Est. Cost/Share $5.99 Unrealized @ Report Date -39.4%

RLX RLX TECHNOLOGY INC 23.7%

Value $39.88M Shares 18,046,195 Share Price $2.21 Est. Cost/Share $5.25 Unrealized @ Report Date -57.9%

TIC ACUREN CORP 9.8%

Value $16.56M Shares 1,500,000 Share Price $11.04 Est. Cost/Share $12.06 Unrealized @ Report Date -8.5%

URGN UROGEN PHARMA LTD 4.0%

Value $6.79M Shares 495,606 Share Price $13.70 Est. Cost/Share $34.01 Unrealized @ Report Date -59.7%

ALLO ALLOGENE THERAPEUTICS INC 1.9%

Value $3.121M Shares 2,920,787 Share Price $1.07 * Est. Cost/Share $17.44 Unrealized @ Report Date -93.5%

— SILEXION THERAPEUTICS CORP 0.1%

Value $91,877 Shares 113,428 Share Price $0.81 Est. Cost/Share $2.01 Unrealized @ Report Date —

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
ULCC	FRONTIER GROUP HLDGS INC	28,061,351	$102M	60.5%	$3.63	$5.99	-39.4%	COM	35909R108
RLX	RLX TECHNOLOGY INC	18,046,195	$39.88M	23.7%	$2.21	$5.25	-57.9%	SPONSORED ADS	74969N103
TIC	ACUREN CORP	1,500,000	$16.56M	9.8%	$11.04	$12.06	-8.5%	COM	00510N102
URGN	UROGEN PHARMA LTD	495,606	$6.79M	4.0%	$13.70	$34.01	-59.7%	COM	M96088105
ALLO	ALLOGENE THERAPEUTICS INC	2,920,787	$3.121M	1.9%	$1.07 *	$17.44	-93.5%	COM	019770106
—	SILEXION THERAPEUTICS CORP	113,428	$91,877	0.1%	$0.81	$2.01	—	SHS NEW	G1281K122